Researchers pinpoint how PARP inhibitors combat BRCA1 and BRCA2 tumor cells
A team of Massachusetts General Hospital (MGH) researchers has discovered how an important class of anti-cancer drugs called PARP inhibitors works, a finding that could help improve treatment and prolong survival for patients ...
Aug 12, 2021
0
247